News

Dengue fever, caused by a flavivirus named DENV, is a major global health challenge, risking almost half of the world's ...
The study is five months long and requires two screening visits, one IV infusion visit, one dengue challenge visit, and 15 follow-up visits ...
Stockhead's Fraser Palamara catches up with Island Pharmaceuticals CEO and managing director Dr David Foster. ... Read More ...
Discover magnetic bead technology for efficient and reliable viral nucleic acid isolation in clinical applications.
Despite this progress, it takes time to discover the right treatment plan, though it’s often a mix of medication, support from healthcare professionals and lifestyle changes. Usually, treatment starts ...
MGM Hospital in Chhatrapati Sambhajinagar has refuted claims made by Shiv Sena MLA Santosh Bangar regarding the treatment of a dengue patient. The hospital stated that the girl's family ...
SHELTON, CT / ACCESS Newswire / April 14, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and ...
Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and most expensive level of clinical testing. The drugmaker said Tuesday that ...
Just like human kids, dogs know few things beat grandparent time. They lavish them with overflowing affection and sneak in extra treats, which, of course, is pure pup heaven! My dogs quickly remember ...
When symptoms are present no current specific pharmacological treatment is available. "Resomelagon has shown to reduce severity of Dengue in experimental animal models and to reduce the ...
Last week And If You Know The History was put on in front of four sell-out audiences at Websters Theatre on Great Western Road, going down a treat as follow ups to the two Bend it shows, Brattbakk and ...
KUALA LUMPUR: The number of dengue fever cases dropped to 1,021 in Epidemiological Week 13 (EW13), from March 23 to 29, compared to 1,129 cases reported the previous week. Health director-general ...